Constitutive androstane receptor: A tumor suppressor and a biomarker for favorable prognosis of liver diseases

Sarah Da Won Bae; Romario Nguyen; Lawrence Yuen; Vincent Lam; Jacob George; Liang Qiao

doi:10.1016/j.gendis.2023.101198

| Sign up

PDF (741.2 KB)

Cite

EndNote(RIS) BibTeX

Collect

Submit Manuscript

Show Outline

Outline

References

Show full outline

Hide outline

Rapid Communication | Open Access

Constitutive androstane receptor: A tumor suppressor and a biomarker for favorable prognosis of liver diseases

Sarah Da Won Bae^{^a}, Romario Nguyen^{^a}, Lawrence Yuen^{^b}, Vincent Lam^{^b}, Jacob George^{^a}(), Liang Qiao^{^a}()

Storr Liver Centre, Westmead Institute for Medical Research, University of Sydney, and Westmead Hospital, Westmead, NSW 2145, Australia

Department of Surgery, Westmead Hospital, Westmead, NSW 2145, Australia

Peer review under responsibility of Chongqing Medical University.

Show Author Information

References

Baes M, Gulick T, Choi HS, Martinoli MG, Simha D, Moore DD. A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements. Mol Cell Biol. 1994;14(3):1544–1552.

Crossref Google Scholar

Bae SDW, Nguyen R, Qiao L, George J. Role of the constitutive androstane receptor (CAR) in human liver cancer. Biochim Biophys Acta Rev Cancer. 2021;1875(2):188516.

Crossref Google Scholar

Chakraborty S, Kanakasabai S, Bright JJ. Constitutive androstane receptor agonist CITCO inhibits growth and expansion of brain tumour stem cells. Br J Cancer. 2011;104(3):448–459.

Crossref Google Scholar

Li Z, Kwon SM, Li D, et al. Human constitutive androstane receptor represses liver cancer development and hepatoma cell proliferation by inhibiting erythropoietin signaling. J Biol Chem. 2022;298(5):101885.

Crossref Google Scholar

Genes & Diseases

Volume 11 Issue 6,
November 2024

Article number: 101198

DOI: 10.1016/j.gendis.2023.101198

Cite this article:

Da Won Bae S, Nguyen R, Yuen L, et al. Constitutive androstane receptor: A tumor suppressor and a biomarker for favorable prognosis of liver diseases. Genes & Diseases, 2024, 11(6): 101198. https://doi.org/10.1016/j.gendis.2023.101198